A comparison between the sales of MPH to the number of patients revealed a disproportionate ratio, indicating high abuse [REF].
Memantine is a NMDA receptor antagonist and is used to treat patients with moderate to severe Alzheimer's disease, but is also used as a neuroenhancement drug [REF].